Janusz Klatka Selected Research

Laryngeal Neoplasms (Laryngeal Cancer)

1/2022	The Clinical, Pathological, and Prognostic Value of High PD-1 Expression and the Presence of Epstein-Barr Virus Reactivation in Patients with Laryngeal Cancer.
4/2020	Imperatorin as a Promising Chemotherapeutic Agent Against Human Larynx Cancer and Rhabdomyosarcoma Cells.
11/2019	T-Lymphocyte Activation Is Correlated With the Presence of Anti-EBV in Patients With Laryngeal Squamous Cell Carcinoma.
1/2017	Cyclooxygenase-2 Inhibition Enhances Proliferation of NKT Cells Derived from Patients with Laryngeal Cancer.
10/2013	7-substituted coumarins inhibit proliferation and migration of laryngeal cancer cells in vitro.
7/2012	Dendritic cell subsets in neoplastic tissue and peripheral blood of laryngeal cancer patients: relation with grade and stage of the disease.
1/2012	[The evaluation of apoptosis in peripheral blood lymphocytes in laryngeal cancer patients].
11/2011	[Evaluation of cytochrome concentration in peripheral blood lymphocytes of patients with laryngeal cancer].
6/2011	The content of cadmium, cobalt and nickel in laryngeal carcinoma.
2/2011	Glutamate receptors in laryngeal cancer cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Janusz Klatka Research Topics

Disease

15	Laryngeal Neoplasms (Laryngeal Cancer) 01/2022 - 03/2002
10	Neoplasms (Cancer) 01/2022 - 01/2008
6	Carcinoma (Carcinomatosis) 06/2011 - 03/2002
3	Squamous Cell Carcinoma of Head and Neck 04/2020 - 02/2011
2	Hemorrhage 10/2011 - 09/2005
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2011 - 01/2011
1	Rhabdomyosarcoma 04/2020
1	Infections 03/2020
1	Epstein-Barr Virus Infections 11/2019
1	Papillomavirus Infections 05/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2016
1	Hearing Loss (Hearing Impairment) 01/2015
1	Vertigo (Positional Vertigo) 01/2015
1	Tinnitus 01/2015
1	Hyperthyroidism 11/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2012
1	Epistaxis (Nosebleed) 10/2011
1	Lymphatic Metastasis 03/2010
1	Neoplasm Metastasis (Metastasis) 03/2010
1	Sinusitis 09/2005
1	Edema (Dropsy) 09/2005
1	Nasal Polyps (Nasal Polyp) 01/2005

Drug/Important Bio-Agent (IBA)

3	Monoclonal AntibodiesIBA 09/2012 - 03/2002
3	Cytidine Triphosphate (CTP)IBA 02/2012 - 01/2011
3	ParaffinIBA 01/2008 - 03/2002
3	Syndecan-1 (Syndecan 1)IBA 01/2004 - 03/2002
2	Immunoglobulin G (IgG)IBA 11/2019 - 01/2008
2	AntibodiesIBA 11/2019 - 01/2008
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2016 - 09/2005
2	Cisplatin (Platino)FDA LinkGeneric 01/2009 - 01/2008
1	Biological ProductsIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Inosine Monophosphate (IMP)IBA 04/2020
1	imperatorinIBA 04/2020
1	Furocoumarins (Furanocoumarins)IBA 04/2020
1	Interferon-gamma (Interferon, gamma)IBA 03/2020
1	thymostimulinIBA 03/2020
1	InterleukinsIBA 03/2020
1	Peptides (Polypeptides)IBA 03/2020
1	Interleukin-4 (Interleukin 4)IBA 03/2020
1	Epstein-Barr Virus Nuclear AntigensIBA 11/2019
1	Viral DNAIBA 05/2017
1	Celecoxib (Celebrex)FDA Link 01/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	MacrolidesIBA 01/2016
1	herniarinIBA 10/2013
1	7-hydroxycoumarin (umbelliferone)IBA 10/2013
1	CoumarinsIBA 10/2013
1	scoparoneIBA 10/2013
1	Methimazole (Thiamazole)FDA LinkGeneric 11/2012
1	Cetuximab (Erbitux)FDA Link 09/2012
1	CytochromesIBA 11/2011
1	CadmiumIBA 06/2011
1	NickelIBA 06/2011
1	CobaltIBA 06/2011
1	Glutamate Receptors (Glutamate Receptor)IBA 02/2011
1	Excitatory Amino Acid AntagonistsIBA 02/2011
1	Metabotropic Glutamate 5 ReceptorIBA 02/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2011
1	Glutamic Acid (Glutamate)FDA Link 02/2011
1	Ionotropic Glutamate ReceptorsIBA 02/2011
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 03/2010
1	Retinoblastoma ProteinIBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	Prednisone (Sone)FDA LinkGeneric 09/2005
1	Clarithromycin (Biaxin)FDA LinkGeneric 09/2005
1	cefuroxime axetil (Ceftin)FDA LinkGeneric 09/2005
1	SteroidsIBA 09/2005
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2005
1	Ki-67 Antigen (Ki 67 Antigen)IBA 01/2005
1	AntigensIBA 01/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 04/2020 - 01/2009
3	Therapeutics 03/2020 - 09/2005
3	Immunotherapy 01/2017 - 07/2012
2	Radiotherapy 09/2012 - 01/2012
1	Cochlear Implantation 01/2015
1	Hearing Aids (Hearing Aid) 01/2015
1	Aftercare (After-Treatment) 10/2011
1	Catheters 10/2011
1	Lymph Node Excision (Lymph Node Dissection) 03/2010
1	Lasers (Laser) 01/2008